Infuvite IV — Class II drug recall D-0264-2017
Ongoing recall by Tri-Coast Pharmacy, reported 2017-01-11, distributed nationwide. Lack of Assurance of Sterility
| Recall number | D-0264-2017 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Ongoing |
| Voluntary or mandated | Voluntary |
| Recalling firm | Tri-Coast Pharmacy, Juno Beach, FL, United States |
| Recall initiated | 2016-11-17 |
| Classified | 2017-01-04 |
| Reported by FDA | 2017-01-11 |
| Distributed | Nationwide (US) |
| Quantity | 161 vials |
| Reason classes | sterility |
| Lot numbers | 07062016D, 08012016E, 08102016D, 08102016E, 08222016C, 08232016C, 08312016A, 09132016C, 09262016C |
Product
Infuvite IV (Ascorbic Acid 200 mg+ Vitamin A Acetate 330 IU+Vitamin D3 200 IU+Thiamine HCL 6 mg+Riboflavin-5-Phosphate Sod 3.6 mg+Pyridoxine HCL 6 mg+Niacinamide 40 mg+Dexpanthenol 15 mg+Vitamin 40E Succinate 10 IU+Phytonadione (K1) 150 mcg/5 mL). 30 ML. Compounded by Tri-Coast Pharmacy.
Reason for recall
Lack of Assurance of Sterility
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0264-2017. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.